Researchers from 12 Spanish hospitals took part with the aim of uncovering clinical and prognostic characteristics in solid organ recipients with COVID-19. The conclusions underscore the need for strict preventive measures in the initial period after transplantation.
New advances in stem cell research will help scientists battle diseases, develop drugs and, eventually, grow organs for transplant.
Black patients with cirrhosis - late-stage liver disease - are about 25% more likely to die compared to non-Hispanic white patients and four times less likely to receive a liver transplant, reports a new study. Estimates of racial disparity in cirrhosis have been limited by a lack of large-scale longitudinal data. The paper is one of the first to link all seven large liver centers in Chicago with the death registry and transplant registry to examine racial disparities in cirrhosis.
What The Study Did: Researchers examined family voucher-based kidney donations and the capability of voucher redemption to provide timely kidney transplants.
In a study published today in the Annals of Internal Medicine, Johns Hopkins Medicine researchers say they believe that, for the first time, there is evidence to show that three doses of vaccine increase antibody levels against SARS-CoV-2 -- the virus that causes COVID 19 -- more than the standard two-dose regimen for people who have received solid organ transplants.
Public health measures designed to reduce the spread of the COVID-19 virus may have fostered a substantial side benefit: A 53 percent drop in hospital admissions for chronic obstructive pulmonary disease (COPD), likely due to a drop in circulating seasonal respiratory viruses such as influenza.
Experts at Cincinnati Children's make early-stage progress at using nanoparticles to deliver treatment for rare lung disease. Details online today in Circulation.
Treating transplant patients with mild to moderate cases of COVID-19 with monoclonal antibodies is safe and helps prevent serious illness, according to a Mayo Clinic study recently published in Open Forum Infectious Diseases. These results are especially important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death.
A new study published in the Journal of the American Geriatrics Society suggests that survival rates after heart transplant surgery are similar in adults ages 18 to 69 and adults ages 70 and older.
Advanced age is often considered a contraindication for heart transplantation, but a new study published in the Journal of the American Geriatrics Society (JAGS) found that post-heart transplant survival among recipients aged ?70 years is not inferior to that of younger recipients.